AstraZeneca Pharmaceuticals LP Brand Manager in the Oncology business unit, AstraZeneca Nordic Baltic Marketing Company located in Denmark, Sweden, Norway or Finland in Espoo, Finland
AstraZeneca is a global, innovation-driven biopharmaceutical business focusing on the discovery, development and commercialization of prescription medicines for some of the world’s most serious diseases. But we're more than one of the world's leading pharmaceutical companies. At AstraZeneca, we're proud to have a unique workplace culture that inspires innovation and collaboration. Here, employees are empowered to express diverse perspectives - and are made to feel valued, energized and rewarded for their ideas and creativity.
The Nordic-Baltic (NOBA) Marketing Company employs around 450 people across 7 countries and has offices located in Södertälje, Copenhagen, Helsinki, Oslo, Tallinn, Riga and Vilnius. By 2025 AstraZeneca NOBA aims to become a recognized leader in its core therapy areas and thus improve the lives of millions of people. This will be achieved by driving excellent launches, building close collaboration and partnerships with stakeholders in health care systems, and developing high performing teams.
Now we are now looking for a Lung cancer Brand Manager in the Oncology business unit - located in Denmark, Sweden,Norway or Finland
Non-small cell lung cancer, NSCLC
Lung cancer is the leading cause of cancer death. The prognosis remain poor and long-term survival rates are low. Approximately 10-15% of Stage IV NSCLC patients in Europe have EGFR-mutated NSCLC.
Stage III NSCLC represents approximately one-third of the NSCLC incidence and the majority of these patients are diagnosed with unresectable tumors. Stage III NSCLC are usually treated with curative intent. The current standard of care is chemotherapy and radiation therapy, followed by active surveillance to monitor for progression.
As Nordic Brand Manager Lung cancer you will contribute to AstraZeneca’s oncology business, one of AstraZeneca’s key growth platforms. In Business Unit Oncology we are committed to put patients first, deliver innovative health solutions and ensure a high medical value for Nordic patients.
In this role, you will be part of the Lung cancer marketing team, primarily by supporting the launch of IMFINZI (durvalumab), soon to be approved by EMA for treatment of stage III NSCLC (non-small cell lung cancer). You will also contribute to the success of TAGRISSO, recently launched in a second indication, first-line EGFR-mutated NSCLC.
IMFINZI is expected to be launched in stage III NSCLC, an area characterized by a high unmet need and few available treatment options. IMFINZI is expected to represent the only new treatment development in stage III Lung cancer during the past 15 years.
TAGRISSO was successfully launched in the Nordics 2,5 years ago for patients diagnosed with T790M-mutated NSCLC. In June 2018, AZ received EU approval for a second indication, EGFR-mutation positive NSCLC, based on
unprecedented efficacy data.
Person in this role
Drives patient support projects & initiatives based on strategies for the brands,
Develops Nordic marketing material based on Global campaigns and specific Nordic brand strategies,
Co-develops new Nordic material with external agencies and provide relevant communication tactics,
Generates market insight together with local implementation team for the business unit,
Delivers brand- & campaign trainings in cooperation with sales- & marketing team,
Supports the Brand planning together with Brand managers,
Drives and executes local brand activities together with local implementation teams
In order to succeed in this role you have
A marketing/finance/science or pharmacy degree
Demonstrated several years of pharma marketing and/or sales experience
Proven strong sense for planning and execution
Good knowledge in Nordic market ethical rules & health care systems
Excellent communication & presentation skills - fluent written and spoken English
Bachelor’s Degree or equivalent, e.g. in Marketing
Proven track record of project leading capabilities
Experience from multicultural business environment
For more information about the position please contact: Cecilia Isacsson, Nordic Franchise Lead Lung cancer, phone: +46 709670117 or at Cecilia.email@example.com. Welcome with your application no later than Friday August 10th. Interviews will be held ongoing during the application period.
AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, sex or sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law. AstraZeneca only employs individuals with the right to work in the country/ies where the role is advertised.